Sandra H. Bridges

1.2k total citations
27 papers, 790 citations indexed

About

Sandra H. Bridges is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Sandra H. Bridges has authored 27 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in Sandra H. Bridges's work include Monoclonal and Polyclonal Antibodies Research (10 papers), HIV Research and Treatment (7 papers) and HIV/AIDS drug development and treatment (5 papers). Sandra H. Bridges is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), HIV Research and Treatment (7 papers) and HIV/AIDS drug development and treatment (5 papers). Sandra H. Bridges collaborates with scholars based in United States, Italy and Canada. Sandra H. Bridges's co-authors include Dan L. Longo, Nava Sarver, John R. Little, M. Patricia D’Souza, J J Mond, Daniella Livnat, James A. Bradac, Ada M. Kruisbeek, B. J. Fowlkes and Jonathan D. Ashwell and has published in prestigious journals such as Science, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Sandra H. Bridges

27 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra H. Bridges United States 14 451 262 238 237 102 27 790
AF Gazdar United States 6 512 1.1× 233 0.9× 125 0.5× 68 0.3× 78 0.8× 10 867
Jordana Griffiths United Kingdom 6 413 0.9× 147 0.6× 92 0.4× 193 0.8× 32 0.3× 6 684
S M Friedman United States 13 600 1.3× 193 0.7× 59 0.2× 267 1.1× 44 0.4× 15 862
Andrew F. Calman United States 8 530 1.2× 626 2.4× 513 2.2× 142 0.6× 217 2.1× 9 1.3k
Terri Jones United States 7 265 0.6× 413 1.6× 247 1.0× 555 2.3× 104 1.0× 10 788
Hanna Dreja United Kingdom 13 438 1.0× 399 1.5× 132 0.6× 87 0.4× 103 1.0× 24 818
Younong Xu United States 15 449 1.0× 308 1.2× 289 1.2× 79 0.3× 198 1.9× 22 877
T Onuma Japan 4 365 0.8× 206 0.8× 57 0.2× 90 0.4× 68 0.7× 4 784
Nilufer P. Seth United States 20 891 2.0× 277 1.1× 98 0.4× 133 0.6× 62 0.6× 24 1.3k
D B Murphy United States 11 510 1.1× 126 0.5× 87 0.4× 174 0.7× 36 0.4× 17 642

Countries citing papers authored by Sandra H. Bridges

Since Specialization
Citations

This map shows the geographic impact of Sandra H. Bridges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra H. Bridges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra H. Bridges more than expected).

Fields of papers citing papers by Sandra H. Bridges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra H. Bridges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra H. Bridges. The network helps show where Sandra H. Bridges may publish in the future.

Co-authorship network of co-authors of Sandra H. Bridges

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra H. Bridges. A scholar is included among the top collaborators of Sandra H. Bridges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra H. Bridges. Sandra H. Bridges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bridges, Sandra H.. (2003). Basic science priorities for therapeutics research.. PubMed. 8(2). 25–7. 2 indexed citations
2.
D’Souza, M. Patricia, Daniella Livnat, James A. Bradac, & Sandra H. Bridges. (1997). Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials. The Journal of Infectious Diseases. 175(5). 1056–1062. 130 indexed citations
3.
Miller, R.H., et al.. (1996). Conference Summary: Novel HIV Therapies—From Discovery to Clinical Proof of Concept. AIDS Research and Human Retroviruses. 12(10). 859–865. 4 indexed citations
4.
Robb, Merlin L., et al.. (1995). Report of the Prevention of Perinatal HIV Type 1 Transmission Workshop: Conference Summary. AIDS Research and Human Retroviruses. 11(10). 1301–1303. 3 indexed citations
5.
Pietrantoni, Marcello, et al.. (1995). Adverse neonatal outcomes following antenatal indomethacin use. American Journal of Obstetrics and Gynecology. 172(1). 415–415. 2 indexed citations
6.
Sarver, Nava & Sandra H. Bridges. (1995). Gene therapy and immune restoration for HIV disease. The Lancet. 345(8947). 427–432. 55 indexed citations
7.
Sheppard, Heather, Sandra H. Bridges, Bonnie J. Mathieson, Mary Clare Walker, & K J Weinhold. (1994). Conference on advances in AIDS vaccine development--1993. Summary: correlates of HIV Immunity Working Group.. PubMed. 10 Suppl 2. S171–6. 3 indexed citations
8.
Sarver, Nava, Roberta Black, Sandra H. Bridges, & Linda A. Chrisey. (1992). Frontiers in HIV-1 Therapy: Fourth Conference of the NIAID National Cooperative Drug Discovery Groups-HIV. AIDS Research and Human Retroviruses. 8(5). 659–667. 12 indexed citations
9.
Jin, Faguang, Richard J. Youle, V G Johnson, et al.. (1991). Suppression of the immune response to immunotoxins with anti-CD4 monoclonal antibodies. The Journal of Immunology. 146(6). 1806–1811. 26 indexed citations
10.
Bridges, Sandra H. & Dan L. Longo. (1990). T cell tumor cure by T cell receptor-mediated activation requires the development of CD8-dependent host immunity.. The Journal of Immunology. 144(5). 2010–2017. 3 indexed citations
11.
Ashwell, Jonathan D., Dan L. Longo, & Sandra H. Bridges. (1987). T-Cell Tumor Elimination as a Result of T-Cell Receptor-Mediated Activation. Science. 237(4810). 61–64. 49 indexed citations
12.
Gregg, Evan O., Sandra H. Bridges, Richard J. Youle, et al.. (1987). Whole ricin and recombinant ricin A chain idiotype-specific immunotoxins for therapy of the guinea pig L2C B cell leukemia.. The Journal of Immunology. 138(12). 4502–4508. 36 indexed citations
13.
Bridges, Sandra H., A M Kruisbeek, & Dan L. Longo. (1987). Selective in vivo antitumor effects of monoclonal anti-I-A antibody on B cell lymphoma.. The Journal of Immunology. 139(12). 4242–4249. 24 indexed citations
14.
Kruisbeek, Ada M., et al.. (1985). Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function.. The Journal of Experimental Medicine. 161(5). 1029–1047. 169 indexed citations
15.
16.
Bridges, Sandra H.. (1978). Myeloma-Specific Transplantation Resistance: a Requirement for Complete Freund's Adjuvant Stimulation of Effectors. The Journal of Immunology. 120(2). 613–618. 4 indexed citations
17.
Bridges, Sandra H., et al.. (1977). Myeloma-Specific Antibodies: Studies of Their Properties and Their Relationship to Tumor Immunity. The Journal of Immunology. 118(6). 2206–2212. 29 indexed citations
18.
Bridges, Sandra H., et al.. (1975). The structure of an immunoglobulin light chain fragment in mouse myeloma cells. Journal of Molecular Biology. 97(1). 11–20. 2 indexed citations
19.
Mauch, Peter, et al.. (1974). The IgM and IgA Immune Response to the TNP Determinant Group in BALB/c Mice. The Journal of Immunology. 112(2). 812–821. 2 indexed citations
20.
Bridges, Sandra H. & John R. Little. (1971). Recovery of binding activity in reconstituted mouse myeloma proteins. Biochemistry. 10(13). 2525–2530. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by AF Gazdar Breakdown of academic impact, for papers by Jordana Griffiths Breakdown of academic impact, for papers by S M Friedman Breakdown of academic impact, for papers by Andrew F. Calman Breakdown of academic impact, for papers by Terri Jones Breakdown of academic impact, for papers by Hanna Dreja Breakdown of academic impact, for papers by Younong Xu Breakdown of academic impact, for papers by T Onuma Breakdown of academic impact, for papers by Nilufer P. Seth Breakdown of academic impact, for papers by D B Murphy
Rankless by CCL
2026